FibroGen Inc (NAS:FGEN)
$ 1.3 0.02 (1.56%) Market Cap: 129.32 Mil Enterprise Value: 101.67 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 57/100

FibroGen Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 04, 2021 / 02:30PM GMT
Release Date Price: $21.15 (+0.33%)
Michael Yee
Jefferies LLC - Analyst

Well, good morning, everyone, and welcome to another great session here on the last day of our 2021 Jefferies Virtual Global Healthcare Conference. We've had a great week, obviously, this week. And one of the teams I'm obviously looking forward to meeting with here today is FibroGen. We have the CEO Enrique Conterno here with us. And obviously, a lot going on at the Company and obviously gearing up for some important decisions and important events this year.

I would just love to start off, Enrique, maybe you could give some opening comments about where FibroGen stands today with roxa. Obviously, both the US and the European developments kind of going on simultaneously. And that would be great as you prepare, obviously, for an AdCom and a whole lot of different scenarios. So that would be great to turn it over to you.

Enrique Conterno
FibroGen, Inc. - CEO

Thank you, Michael, and great to be here, be able to chat with you once again. We continue to be enthusiastic and excited about the opportunity of roxadustat to

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot